Cleared Traditional

K833579 - MODIF. OF EMIT URINE AMPHETAMINE

K833579 is an FDA 510(k) clearance for MODIF. OF EMIT URINE AMPHETAMINE, manufactured by Syva Co.. The device is a Class 2 Toxicology device with product code DKZ cleared through the Traditional 510(k) pathway after a 106-day FDA review.

K833579 · Syva Co. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
106d
Days
Class 2
Risk

K833579 is an FDA 510(k) clearance for the MODIF. OF EMIT URINE AMPHETAMINE. Classified as Enzyme Immunoassay, Amphetamine (product code DKZ), Class II - Special Controls.

Submitted by Syva Co. (Mchenry, US). The FDA issued a Cleared decision on January 26, 1984 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3100 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all Syva Co. devices

FDA 510(k) Submission Details - K833579

510(k) Number K833579 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 12, 1983
Decision Date January 26, 1984
Days to Decision 106 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 87d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DKZ Device Classification - Class 2, Special Controls

Product Code DKZ Enzyme Immunoassay, Amphetamine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DKZ Enzyme Immunoassay, Amphetamine

All 184
Devices cleared under the same product code (DKZ) and FDA review panel - the closest regulatory comparables to K833579.
TDX AMPHETAMINE METHAMPHETAMINE
K853879 · Abbott Laboratories · Oct 1985
EMIT D.A.U. AMPHETAMINE ASSAY
K842674 · Syva Co. · Sep 1984
EMIT 700 AMPHETAMINE ASSAY NEW PRODUCT
K843458 · Syva Co. · Sep 1984
EMIT-STM AMPHETAMINE ASSAY
K802623 · Syva Co. · Nov 1980
EMIT AMPHETAMINE CONFIRMATION REAGENT
K760936 · Syva Co. · Nov 1976
ASSAY, AMPHET. NDC#11711-0127-1 COULTER
K760196 · Coulter Electronics, Inc. · Aug 1976